3/13/2025 | DD | Market Commentary: Hertz slides; Fortress drops; Sunnova up; pharma pressured on Mallinckrodt, Endo deal
|
4/23/2024 | DD | Endo exits Chapter 11 bankruptcy following sale to lender entity
|
3/26/2024 | DD | Endo International reports $17.99 million net loss for January
|
3/20/2024 | DD | Endo International reports $9.02 million net loss for December
|
3/19/2024 | DD | Endo secures confirmation of Chapter 11 plan of reorganization
|
2/29/2024 | DD | Endo International reaches settlements with Department of Justice
|
1/25/2024 | DD | Endo International gets 39-day extension of exclusive plan periods
|
1/16/2024 | DD | Endo International gets conditional approval of disclosure statement
|
1/9/2024 | DD | Endo International seeks 39-day extension of exclusive plan periods
|
12/29/2023 | DD | Endo International reports $13.1 million net loss for November
|
12/19/2023 | DD | Endo International files new Chapter 11 plan, disclosure statement
|
11/29/2023 | DD | Endo International reports $50.9 million net loss for September
|
11/20/2023 | DD | Endo International gets 90-day extension of exclusive plan periods
|
10/11/2023 | DD | Endo International seeks 90-day extension of exclusive plan periods
|
8/29/2023 | DD | Endo International reports $35.65 million net loss for June
|
8/24/2023 | DD | Endo International mediation extended through mid-September
|
8/2/2023 | DD | Endo International mediation extended again, now through mid-August
|
7/31/2023 | DD | Endo International wins lengthy extension of exclusive plan periods
|
7/18/2023 | DD | Endo’s proposed sale violates bankruptcy code, U.S. trustee says
|
7/14/2023 | DD | Market Commentary: Trucking paper strong; AMC, Endo notes trade; Frontier drops; Rite Aid lower on week
|
7/13/2023 | DD | Endo International mediation extended again, now through Aug. 4
|
7/7/2023 | DD | Endo International hastily files creditor sale agreement
|
6/26/2023 | DD | Endo International’s asset sale hearing moved to Aug. 4
|
6/22/2023 | DD | Endo International mediation extended through July 7
|
6/21/2023 | DD | Endo terminates sale process, will seek sale to stalking horse bidder
|
6/13/2023 | DD | Endo International seeks lengthy extension of exclusive plan periods
|
5/31/2023 | DD | Endo International mediation extended through June 16
|
5/26/2023 | DD | Endo International reports $46.49 million net loss for March
|
4/25/2023 | DD | Endo International mediation extended through end of May
|
4/21/2023 | DD | Endo International mediator wants to extend mediation through May
|
4/4/2023 | DD | Endo receives exclusivity extension, approval of bid procedures
|
3/22/2023 | DD | Endo International receives short extension of exclusive plan periods
|
3/16/2023 | DD | Endo International mediation extended through end of March
|
3/6/2023 | DD | Endo International, first-lien lenders reach settlement with unsecured, opioid creditors
|
1/27/2023 | DD | Endo ordered to mediate over bid procedures, exclusivity extension
|
1/26/2023 | DD | Endo committees seek to prosecute claims against lenders, execs
|
1/13/2023 | DD | Endo committee blasts ‘audacious’ motion for exclusivity extension
|
1/9/2023 | DD | Endo’s proposed sale process draws more creditor pushback
|
1/6/2023 | DD | Endo’s proposed sale process draws objection from noteholders
|
1/3/2023 | DD | Endo International reports $32.79 million net loss for October
|
12/30/2022 | DD | Market Commentary: Outlook 2023: Distressed market on watch for prospects as defaults climb; retail in focus
|
12/30/2022 | BKCVDDEMHY | Outlook 2023: Higher defaults in store across markets; distressed debt exchange leading cause
|
12/15/2022 | DD | Endo seeks lengthy exclusivity extension to focus on sale process
|
12/6/2022 | DD | Endo committee, noteholders want more time to discuss sale alternative
|
12/2/2022 | DD | Endo’s stalking horse lender draws objection from U.S. trustee
|
11/23/2022 | DD | Endo proposes sale process with first-lien debtholders as stalking horse
|
11/9/2022 | DD | Market Commentary: Endo notes rise; Rite Aid paper up following downgrades; Party City extends decline
|
11/8/2022 | DD | Endo wants to pay benefits, severance over trustee objection
|
11/2/2022 | DD | Market Commentary: Drugstore, pharmaceutical paper mixed following opioid deal; Rite Aid notes lower
|
10/20/2022 | DD | Endo International granted final approval to use cash collateral
|
10/18/2022 | DD | Endo International reports $3.67 million net profit for August
|
10/6/2022 | DD | Endo opioid claimant committee has ‘grave concerns’ over trusts
|
9/14/2022 | DD | Market Commentary: Endo notes decline as Nasdaq sets stock delisting date; Bausch mixed; CHS weakens
|
9/13/2022 | DD | Market Commentary: Diamond Sports secured notes lower; CURO drops to 50s handle; CHS paper softens
|
9/6/2022 | DD | Endo International trustee lodges objection for request for redaction
|
9/2/2022 | DD | Endo International’s official committee of unsecured creditors named
|
9/1/2022 | DD | Market Commentary: Bausch Health paper declines under heavy secondary pressure; Endo lower; AMC softens
|
8/29/2022 | DD | Market Commentary: Endo notes gain; Community Health softens; Toledo Hospital improves; Bausch declines
|
8/24/2022 | DD | Market Commentary: Distressed pharmaceutical paper mixed; Bausch notes skid; Endo improves; Revlon higher
|
8/22/2022 | DD | Market Commentary: Bed Bath & Beyond lower; AMC bonds, stock decline; National CineMedia drops; Bausch down
|
8/19/2022 | DD | Endo International granted interim approval to use cash collateral
|
8/19/2022 | DD | Endo lists debt impacted by event of default via bankruptcy filing
|
8/19/2022 | DD | Market Commentary: Bed Bath & Beyond paper slides over 10 points, stock plunges; Rite Aid softens; Endo up
|
8/19/2022 | BKDDHY | Moody's drops Endo's PDR to D-PD
|
8/18/2022 | DD | Market Commentary: Endo up post-bankruptcy filing; Mallinckrodt soft; Bausch pressured; trading thin
|
8/18/2022 | DD | Endo ‘proudly abandoned’ reorganization process, noteholders say
|
8/17/2022 | DD | Market Commentary: Endo notes gain on bankruptcy news; Mallinckrodt improves; Bausch drops; Lannett flat
|
8/17/2022 | BKDDHY | S&P drops Endo to D on Chapter 11 filing
|
8/17/2022 | DDHY | Endo International files Chapter 11 with $6 billion credit bid from first-lien holders
|
8/15/2022 | DD | Market Commentary: Kohl’s lower ahead of earnings report; Mallinckrodt quiet after Friday’s slide; Endo off
|
8/12/2022 | DD | Market Commentary: AMC secured notes move higher; Avaya bonds shed over 3 points; Bausch Health improves
|
8/10/2022 | DD | Market Commentary: Endo notes trade higher; Qurate Retail, QVC paper perks up; global defaults rise
|
8/10/2022 | DDHY | Endo noteholder group says potential bankruptcy filing unwarranted
|
8/9/2022 | DD | Market Commentary: Endo notes mixed on potential bankruptcy; Bausch declines; CHS softens; Avaya drops
|
8/9/2022 | DDHY | Endo negotiations with creditors continue; could file Chapter 11 soon
|
8/5/2022 | BKCVDDEMHY | Prospect News reports two new defaults for July 28-Aug. 3
|
7/28/2022 | DD | Market Commentary: Community Health bonds move up; Endo mixed; GPS, Carrols Restaurant paper mostly quiet
|
7/28/2022 | DDHYLM | Endo cures default for 2028 notes, pays $38 million in interest
|
7/27/2022 | DD | Market Commentary: Pharma bonds mixed following Teva opioid settlement; Endo mostly lower; Bausch improves
|
7/22/2022 | DD | Market Commentary: Community Health notes stronger; Endo, Bausch paper improves; higher default rates eyed
|
7/15/2022 | DD | Market Commentary: Endo notes mixed on more missed bond payments; Bausch paper improves; Community Health up
|
7/15/2022 | DDHY | Endo opts not to make $1.9 million coupon payments on notes due 2023
|
7/14/2022 | DD | Market Commentary: Bausch paper extends losses; Endo bonds mostly lower; Rite Aid notes flat, CDS spreads firm
|
7/8/2022 | BKCVDDEMHY | Prospect News reports five new defaults for June 30-July 6
|
7/7/2022 | DD | Market Commentary: Endo bonds rally; Rite Aid notes climb; energy paper trades higher as oil prices advance
|
7/5/2022 | DD | Market Commentary: Distressed energy bonds down as crude oil prices slide; Transocean, Talen trade lower
|
7/1/2022 | DD | Market Commentary: Pre-holiday action thins; PROG bonds down; Bed Bath & Beyond lower; Exela declines
|
6/30/2022 | DD | Market Commentary: Endo notes mixed on missed payment; Bed Bath & Beyond lower; Rite Aid paper declines
|
6/30/2022 | DDHY | Endo opts not to make $38 million coupon payment on 6% notes due 2028
|
6/30/2022 | BKDDHY | S&P cuts Endo International
|
6/28/2022 | DD | Market Commentary: Rite Aid down after tender offer wraps; Endo up; Bausch lower; EnLink Midstream softens
|
6/27/2022 | DDHYLM | Endo investors form group of holders of unsecured notes
|
6/27/2022 | DD | Market Commentary: Endo bonds mostly higher; WeWork unchanged; Talen bonds quiet; high-grade notes decline
|
6/23/2022 | DD | Market Commentary: Endo International notes volatile; Carnival, Royal Caribbean lower; Weatherford down
|
6/21/2022 | DD | Market Commentary: Revlon moves out of single digits; Endo bonds mixed; Lowe’s paper trades with 80s handle
|
6/17/2022 | DD | Market Commentary: Revlon notes higher; Endo improves; PBF declines; high-grade paper under pressure
|
6/10/2022 | DD | Market Commentary: Talen Energy mixed; AMC secured notes decline; Endo trades higher; Clear Channel down
|
6/6/2022 | DD | Market Commentary: Revlon up on debt talks; Endo paper mostly soft ahead of board fight; secondary thin
|
5/31/2022 | BKDDHY | Moody's slices Endo
|
5/26/2022 | DD | Market Commentary: AMC second-lien notes rally; Rite Aid paper, CDS spreads improve; Endo lower; Talen off
|
5/25/2022 | DD | Market Commentary: Mallinckrodt moves higher; Endo senior notes weaken; Bed Bath & Beyond lower; CURO off
|
5/24/2022 | DD | Market Commentary: Endo bonds drop; Mallinckrodt paper declines to 30s handle; Artera Services improves
|
5/20/2022 | BKDDHY | S&P trims Endo International
|
5/18/2022 | DD | Market Commentary: Endo bonds mixed on restructuring reports; Michaels declines; Triumph Group notes slip
|
5/17/2022 | DD | Market Commentary: QVC owner’s bonds under pressure; Endo edges up; bankrupt Talen Energy paper declines
|
5/16/2022 | DD | Market Commentary: Endo pharma bonds trade mixed; Rite Aid paper edges higher; AMC secured issue softens
|
5/10/2022 | DD | Market Commentary: Talen paper gains after bankruptcy filing; Endo under pressure; distressed returns weak
|
5/9/2022 | DD | Market Commentary: Frontier notes falls on new offering; Endo losses mount; Party City down double digits
|
5/6/2022 | DD | Market Commentary: Endo notes sink to teens in heavy secondary action; Mallinckrodt quiet; Telesat gains
|
5/6/2022 | BKCVDDEMIGPV | Market Commentary: Junk returns plummet past negative 9%; Endo craters; DISH falls post-earnings
|
4/28/2022 | DD | Market Commentary: Carvana paper flirts with distressed space; Endo under pressure; Mallinckrodt softens
|
4/22/2022 | DD | Market Commentary: Carvana notes edge up after stock sale; Endo under pressure; Mallinckrodt paper higher
|
4/20/2022 | DD | Market Commentary: Distressed pharmaceutical paper mixed; Endo secureds lower; Mallinckrodt up; Telesat off
|
4/19/2022 | DD | Market Commentary: Endo notes decline following opioid settlement; Diamond Sports drops; Talen Energy up
|
3/25/2022 | DD | Market Commentary: Talen notes trade mixed; Transocean up; Endo dips; distressed traders await ‘pain’
|
3/11/2022 | BKCVDDEMIGPV | Market Commentary: Carpenter Technology prices in junkland; Kraft Heinz gains rising star status; Endo plummets
|
3/11/2022 | DD | Market Commentary: Endo secured notes sink in heavy secondary supply; Mallinckrodt softens; Diamond Sports mixed
|
3/10/2022 | DD | Market Commentary: PBF, Transocean, Nine Energy slip, mostly higher on week; selling fizzles; Endo down
|
3/9/2022 | DD | Market Commentary: Distressed pharma bonds drop as Purdue settlement cleared; Endo off; Mallinckrodt mixed
|
3/8/2022 | DD | Market Commentary: Distressed energy bonds climb; Transocean, PBF improve; Nine Energy rallies; Endo up
|
3/4/2022 | DD | Market Commentary: Distressed energy paper up as oil soars; Transocean, PBF bonds gain; Endo declines
|
3/3/2022 | DD | Market Commentary: Distressed pharma bonds mixed; Mallinckrodt up; Endo flat to higher; Lannett soft
|
3/2/2022 | DD | Market Commentary: AMC second-lien notes higher; Endo bonds unchanged to softer; Skillz secured paper up
|
3/1/2022 | DD | Market Commentary: Endo notes slide; Diamond Sports steady; Transocean paper rallies; CURO, Coinbase trade
|
3/1/2022 | BKCVDDEMIGPV | Market Commentary: BellRing returns in junkland; rate-sensitive names up; Endo drops, New Fortress improves
|
2/9/2022 | DD | Market Commentary: AMC up as stronger buyback capacity eyed; distressed pharma paper mixed; Yuzhou lower
|
2/4/2022 | DD | Market Commentary: Diamond Sports mixed; Mallinckrodt gains as bankruptcy end nears; Endo soft; TPC down
|
1/24/2022 | DD | Market Commentary: Endo, Mallinckrodt, Team Health lower; Envision Healthcare up; PBF, Talen drop; AMC off
|
12/31/2021 | DD | Market Commentary: Outlook 2022: Distressed debt shrinks in 2021; cautious sentiment abounds heading into 2022
|
12/21/2021 | DD | Market Commentary: AMC notes on mend; Endo paper mixed; Mallinckrodt slides 5 points; Talen Energy higher
|
12/17/2021 | DD | Market Commentary: Endo lower; Mallinckrodt paper quiet; AMC down; National CineMedia dips; Shimao softens
|
12/15/2021 | DD | Market Commentary: Talen bonds eyed; AMC declines; Endo volatile; PBF, Diamond Sports improve; Sunac mixed
|
12/14/2021 | DD | Market Commentary: Endo lower; Mallinckrodt flat; Air Methods gains; AMC soft; 99 Cents off; PBF drops
|
12/8/2021 | DD | Market Commentary: Mallinckrodt bonds mixed; Endo up; Envision, Diamond Sports, GEO decline; Sunac down
|
11/29/2021 | DD | Market Commentary: Team Health notes gain; Air Methods, Endo decline; Telesat mixed; Evergrande better
|
11/24/2021 | DD | Market Commentary: Talen notes higher; Moss Creek, Summit, PBF decline; Nordstrom drops; Endo softens
|
11/12/2021 | DD | Market Commentary: TPC drops; Talen soft; Bausch, MultiPlan under pressure; Endo improves; Evergrande up
|
11/10/2021 | DD | Market Commentary: Diamond Sports notes higher; Endo edges down; Mallinckrodt up; Kaisa, Evergrande soften
|
11/9/2021 | DD | Market Commentary: Diamond Sports extends gains; PBF better; Talen declines; pharma mixed; Kaisa drops
|
11/5/2021 | DD | Market Commentary: Endo bonds improve; Mallinckrodt up; Kaisa, Evergrande trade lower; secondary quiets
|
11/4/2021 | DD | Market Commentary: Diamond Sports soft; Kaisa, China Evergrande weakens; Endo, Mallinckrodt, Air Methods up
|
11/3/2021 | DD | Market Commentary: Transocean notes decline as oil sinks; Endo, Mallinckrodt edge higher; Exela mostly flat
|
11/2/2021 | DD | Market Commentary: Endo rallies; Mallinckrodt gets lift; Talen Energy rebounds; Ligado declines; Telesat up
|
11/1/2021 | DD | Market Commentary: Endo notes higher; Mallinckrodt mixed; Team Health, Envision improve; Air Method paper quiet
|
10/7/2021 | DD | Market Commentary: Oil prices lift energy bonds; Talen up; Endo gains; Mallinckrodt shows signs of recovery
|
10/1/2021 | DD | Market Commentary: Endo, Mallinckrodt higher; Evergrande mixed; Greenland, Fantasia quiet; Peabody jumps
|
9/29/2021 | DD | Market Commentary: Endo rallies on settlement; Mallinckrodt sinks; Evergrande, Fantasia drop; Transocean up
|
9/24/2021 | DD | Market Commentary: Mallinckrodt declines; PBF active; Shelf Drilling, Talen up; China Evergrande softens
|
9/21/2021 | DD | Market Commentary: China Evergrande notes trade up; Fantasia, Tianji lower; Talen rallies; Endo better
|
9/13/2021 | DD | Market Commentary: Endo, Mallinckrodt higher following settlement; Wesco notes improve; Diamond Sports up
|
9/10/2021 | DD | Market Commentary: Endo rallies on latest opioid settlement; Mallinckrodt mixed; Envision notes soft
|
9/2/2021 | BKDDHY | S&P lowers Endo International
|
8/26/2021 | DD | Market Commentary: PBF mostly higher, strong on week; Talen bonds rebound; Endo, Mallinckrodt notes rise
|
8/26/2021 | BKDDHY | Moody's downgrades Endo
|
8/19/2021 | DD | Market Commentary: Talen bonds slide; Transocean, NGL lower; PBF edges up; Midas quiets; Endo softens
|
8/11/2021 | DD | Market Commentary: Laredo, Transocean bonds weak; AMC gives back gains; Endo declines; Mallinckrodt up
|
8/6/2021 | DD | Market Commentary: Rebound plays up; AMC flat; energy paper mixed; Intelsat Jackson drops; Diamond Sports better
|
8/5/2021 | DD | Market Commentary: AMC bounces back; Transocean drops; Diamond Sports mostly flat; Endo better; Mallinckrodt off
|
8/3/2021 | DD | Market Commentary: PBF extends declines; Talen recovers; Endo, Mallinckrodt soften; AMC weakens; liquidity thin
|
7/30/2021 | DD | Market Commentary: China Evergrande dives; Peabody rises; Washington Prime flat; Endo slips; Mallinckrodt up
|
7/28/2021 | DD | Market Commentary: Talen paper mixed; Transocean flat; Endo bonds calm; Washington Prime soft; AMC better
|
7/27/2021 | DD | Market Commentary: Energy bonds pressured; Transocean, NGL decline; Peabody improves; Endo notes soften
|
7/26/2021 | DD | Market Commentary: Evergrande, AMC decline; Endo, Intelsat Jackson flat; Mallinckrodt up; Transocean drops
|
7/23/2021 | DD | Market Commentary: Endo stronger on week; Mallinckrodt flat; Navios, PBF dip; Exela ‘finds ceiling’
|
7/22/2021 | DD | Market Commentary: Endo up on settlement; Mallinckrodt mixed; market returns eyed; Transocean, Callon rise
|
7/21/2021 | DD | Market Commentary: Offshore bonds up; Transocean higher; Talen mixed; Peabody better; Endo, AMC improve
|
7/20/2021 | DD | Market Commentary: Energy steadies; Transocean mixed; Shelf Drilling flat; Callon, Endo, AMC bonds higher
|
7/2/2021 | DD | Market Commentary: Exela gains; Talen, PBF lower; Endo declines; Mallinckrodt better; Diamond Sports mixed
|
5/20/2021 | DD | Market Commentary: Talen, Gran Tierra bonds decline; Peabody, TPC, Hertz higher; Mallinckrodt softens
|
4/13/2021 | DD | Market Commentary: Diamond Sports declines; Talen, Nine Energy gain; Endo softens; Mallinckrodt improves
|
3/12/2021 | BKCVDDEMIGPV | Market Commentary: More new junk than expected Friday; Scotts, Tempur Sealy lag, Endo, Entercom at a premium
|
12/2/2020 | DD | Market Commentary: Bombardier notes better after sale conditions met; Endo up on BioSpecifics acquisition
|
10/13/2020 | DD | Market Commentary: Mallinckrodt notes rise after bankruptcy filing; AMC heads lower following cash warning
|
8/4/2020 | DD | Market Commentary: Mallinckrodt notes rise on second-quarter earnings beat; Valaris up in energy space
|
7/7/2020 | DD | Market Commentary: Endo notes better on drug approval; Diebold Nixdorf trades higher as new notes offered
|
5/29/2020 | DD | Market Commentary: PG&E notes up after regulators approve restructuring; Party City jumps in retail space
|
5/15/2020 | DD | Market Commentary: J.C. Penney notes trade higher before bankruptcy filing; WeWork up on quarterly results
|
5/14/2020 | DD | Market Commentary: Intelsat notes active after bankruptcy filing; Endo flat to slightly up amid exchange
|
5/14/2020 | BKDDHY | Moody’s rates Par notes B2, Endo notes Caa2
|
5/14/2020 | BKDDHY | S&P assigns Endo notes CCC+
|
5/7/2020 | DD | Market Commentary: Hertz notes in focus as ratings downgraded; Bombardier paper active on earnings miss
|
5/5/2020 | DD | Market Commentary: Hertz notes active on forbearance news; L Brands paper drops after asset sale nixed
|
4/9/2020 | DD | Market Commentary: PG&E notes gain on plan support; Occidental Petroleum bonds rise as OPEC strikes deal
|
4/8/2020 | DD | Market Commentary: Intelsat notes trade higher after financing news; Oasis Petroleum eyed as ratings cut
|
3/16/2020 | DD | Market Commentary: Frontier Communications declines as interest payment skipped; Whiting notes active
|
3/9/2020 | DD | Market Commentary: Diamond Offshore drops on ratings cut; energy tranches crash; Intelsat lower
|
3/6/2020 | DD | Market Commentary: Whiting falls as ratings downgraded; PG&E lower in utilities space
|
3/5/2020 | DD | Market Commentary: California Resources notes in focus amid early tender results; Intelsat trades lower
|
3/4/2020 | DD | Market Commentary: Titan notes decline after posting Q4 loss; Uniti rises as ratings put on positive watch
|
3/3/2020 | DD | Market Commentary: Mallinckrodt notes lower after government files lawsuit; GTT improves on ratings shift
|
3/2/2020 | DD | Market Commentary: Uniti climbs as litigation settlement reached; GTT declines after posting Q4 loss
|
2/28/2020 | DD | Market Commentary: Range Resources notes weaken after mixed earnings; PG&E lower as regulator levies fine
|
2/27/2020 | DD | Market Commentary: Whiting driven down amid quarterly loss; J.C. Penney notes eyed in retail sector
|
2/26/2020 | DD | Market Commentary: Chesapeake Energy notes weaken on earnings report; Endo declines despite posting profit
|
2/26/2020 | BKBWDDHYLM | Endo 2019 debt refi transactions garner lower debt, revised revolver
|
2/25/2020 | DD | Market Commentary: Mallinckrodt jumps on bankruptcy settlement; California Resources eyed in energy space
|
2/25/2020 | BKCVDDEMIGPV | Market Commentary: Bausch offering eyed; Mallinckrodt skyrockets; Endo, Teva gain; Tupperware nosedives
|
2/24/2020 | DD | Market Commentary: Mallinckrodt worse after bankruptcy talk; California Resources down as ratings cut
|
2/21/2020 | DD | Market Commentary: California Resources better on exchange offer; Intelsat falls as more revenue sought
|
2/20/2020 | DD | Market Commentary: Intelsat notes rise after Q4 earnings report; L Brands eyed amid asset sale, CEO exit
|
2/19/2020 | DD | Market Commentary: PG&E dips as further mediation ordered; Endo notes gain amid executive appointments
|
2/12/2020 | DD | Market Commentary: Whiting lower after financial adviser report; Endo, Mallinckrodt lifted in pharma space
|
1/21/2020 | DD | Market Commentary: McDermott eyed after bankruptcy filing; L Brands notes lower despite analyst upgrade
|
1/17/2020 | DD | Market Commentary: Chesapeake Energy notes lower amid ratings upgrade; WeWork down after Q4 pullback
|
1/16/2020 | DD | Market Commentary: PG&E notes trade better amid creditor negotiations; Intelsat improves in telecom space
|
1/14/2020 | DD | Market Commentary: PG&E trades higher as company seeks creditor deal; EQT notes down on impairment charge
|
1/13/2020 | DD | Market Commentary: PG&E bonds better on potential tax news; Mallinckrodt gains as company touts debt cut
|
1/10/2020 | DD | Market Commentary: PG&E notes trade higher amid payout dispute; Endo active as settlement announced
|
12/31/2019 | DD | Market Commentary: Outlook 2020: PG&E looks for exit; energy sees further risk; telecoms on the brink
|
12/9/2019 | DD | Market Commentary: PG&E bonds gain on settlement news; Mallinckrodt higher despite rating downgrade
|
11/27/2019 | DD | Market Commentary: PG&E better after bankruptcy court ruling; Mallinckrodt notes rise in pharma space
|
11/26/2019 | DD | Market Commentary: Mallinckrodt gains despite federal probe; McDermott notes hit new low in energy space
|
11/5/2019 | DD | Market Commentary: Chesapeake falls after earnings report; Mallinckrodt mixed on earnings, exchange offers
|
10/28/2019 | DD | Market Commentary: PG&E dives as blackouts, wildfires persist; McDermott declines after ratings downgrade
|
10/25/2019 | DD | Market Commentary: PG&E notes drop amid wildfire worries; WeWork trades higher as rescue funding detailed
|
10/24/2019 | DD | Market Commentary: PG&E notes trade lower amid more power blackouts; Teva paper declines in pharma space
|
10/17/2019 | DD | Market Commentary: Teva active as settlement reportedly nears; Gulfport Energy rises on production news
|
10/16/2019 | DD | Market Commentary: Pharma names improve on settlement news; Rite Aid declines after ratings downgrade
|
10/9/2019 | DD | Market Commentary: U.S. Steel notes weaken after CFO departure; PG&E lower amid exclusivity termination
|
10/7/2019 | DD | Market Commentary: PG&E lower amid victim payout dispute; Bristow notes up as bankruptcy exit expected
|
10/1/2019 | DD | Market Commentary: U.S. Steel notes lower on acquisition news; Mallinckrodt active in pharmaceutical space
|
9/30/2019 | DD | Market Commentary: Mallinckrodt debt trades lower after settlement finalized; Superior Energy active
|
9/25/2019 | DD | Market Commentary: Dean Foods lower after CFO departure; Diamond Offshore down amid ratings downgrade
|
9/23/2019 | DD | Market Commentary: PG&E lower in reorganization dispute; McDermott notes decline amid ratings downgrade
|
9/20/2019 | DD | Market Commentary: McDermott better on asset sale talk; PG&E paper rises amid dueling reorganization plans
|
9/19/2019 | DD | Market Commentary: Chesapeake Energy notes lower after senior note swap; Teva weakens in pharma space
|
9/13/2019 | DD | Market Commentary: PG&E bonds lower on insurance settlement news; Mallinckrodt better in pharma space
|
9/10/2019 | DD | Market Commentary: PG&E notes lower after restructuring plan submitted; Mallinckrodt lifted on asset sale
|
9/6/2019 | DD | Market Commentary: Mallinckrodt mixed on settlement news; PG&E better in run-up to restructuring plan
|
9/5/2019 | DD | Market Commentary: Mallinckrodt sinks on restructuring talk; Bed Bath better after announcing revamp plan
|
8/28/2019 | BKCVDDEMIGPV | Market Commentary: Pharma space under pressure; Rackspace higher; Tallgrass negative; oil names rise
|
8/28/2019 | DD | Market Commentary: Pharma names lower on more settlement news; Rackspace improves after conference call
|
8/27/2019 | BKCVDDEMIGPV | Market Commentary: Pharma names see negativity; Range Resources varies; GTT declines
|
8/27/2019 | DD | Market Commentary: Endo, Teva drop post-settlement news; Range Resources active, flat after downgrade
|
8/26/2019 | BKCVDDEMIGPV | Market Commentary: Endo higher in pharma space; SRC Energy jumps on acquisition news; Dish better
|
8/26/2019 | DD | Market Commentary: Endo, Mallinckrodt notes better on settlement news; DISH rises after analyst upgrade
|
8/23/2019 | BKCVDDEMIGPV | Market Commentary: Oil names negative; Sinclair, L Brands mixed; $10.4 billion of inflows; indexes better
|
8/23/2019 | DD | Market Commentary: L Brands bonds lower after analyst downgrade; Endo paper declines in pharma space
|
8/22/2019 | DD | Market Commentary: L Brands bonds active, mixed after earnings report; CBL eyed after delisting notice
|
8/21/2019 | BKCVDDEMIGPV | Market Commentary: Elanco varies after animal health buyout news; oil names trend positive; PG&E rises
|
8/21/2019 | DD | Market Commentary: L Brands lower on earnings anticipation; Endo International notes continue to rise
|
8/20/2019 | DD | Market Commentary: Endo International gains after lawsuit settlement news; PG&E weakens in utilities space
|
8/8/2019 | DD | Market Commentary: GTT, Rayonier dive on quarterly misses; Teva rises in pharma space
|
8/7/2019 | DD | Market Commentary: Frontier, Teva down despite earnings beat; Denbury rises after quarterly numbers
|
8/6/2019 | BKCVDDEMIGPV | Market Commentary: NCR on tap; Sirius postpones offering; sell-off in oil patch continues; Endo active, mixed
|
8/6/2019 | DD | Market Commentary: Endo rises despite negative earnings, sector negativity; Adient gains on quarterly report
|
7/30/2019 | DD | Market Commentary: McDermott slips after earnings, guidance; Intelsat better on mixed earnings
|
7/29/2019 | DD | Market Commentary: Teva higher as settlement reached; LSC Communications declines on downgrade
|
7/15/2019 | DD | Market Commentary: Endo, Teva under pressure; Intelsat drops; Cincinnati Bell recoups losses
|
7/1/2019 | BKCVDDEMIGPV | Market Commentary: CSC Holdings prices; Western Digital gains; Endo drops; Coty down on restructuring
|
7/1/2019 | DD | Market Commentary: Weatherford drops on bankruptcy filing; Endo lower after ratings downgrade
|
7/1/2019 | BKDDHY | Moody’s downgrades Endo
|
6/18/2019 | DD | Market Commentary: Windstream higher as Uniti lease in question; PetSmart declines in retail
|
6/3/2019 | DD | Market Commentary: Teva better after analyst upgrade; Navios mixed on debt offering
|
5/20/2019 | DD | Market Commentary: Alta Mesa lower on SEC investigation; U.S. Steel negative after trade news
|
5/16/2019 | DD | Market Commentary: U.S. Steel rises despite trade climate; Navios gains after asset manager buys stake
|
5/15/2019 | DD | Market Commentary: Teva lower on continued scrutiny; Chaparral Energy drops after downgrade
|
5/13/2019 | DD | Market Commentary: Teva loses as legal troubles mount; Weatherford drops as bankruptcy expected
|
3/28/2019 | DD | Market Commentary: PG&E mixed as creditors propose bankruptcy exit plan; Endo off on early tender results
|
3/26/2019 | BKCVDDEMIGPV | Market Commentary: Allison Transmission oversubscribed; Endo, Par Pharma jump; Bed Bath & Beyond surges
|
3/26/2019 | DD | Market Commentary: Endo up as sector peer settles lawsuit; Bed Bath & Beyond rises as investors push CEO exit
|
3/15/2019 | DD | Market Commentary: PHI notes drop after bankruptcy filing; EP Energy issues crater after earnings report
|
3/14/2019 | DD | Market Commentary: Endo notes positive as company begins debt refinancing; PHI issues dip over maturity fears
|
3/14/2019 | BKDDHY | Moody’s cuts Endo debt, rates revolver, notes Ba3
|
3/14/2019 | BKDDHY | S&P trims Endo International, rates Par Pharma notes B+
|
3/6/2019 | BKCVDDEMIGPV | Market Commentary: Manitowoc, Target Hospitality on tap; Scientific Games gains; Credit Acceptance weakens
|
3/6/2019 | DD | Market Commentary: Dean Foods notes lose after ratings downgrade; PG&E issues higher as court mulls oversight requirements
|
7/30/2018 | DD | Market Commentary: Community Health notes begin week mixed; American Tire continues climb amid reorganization
|
7/9/2018 | BKCVDDEMIGPV | Market Commentary: Ceva launches offering; California Resources, SFR Group in focus; Endo sees gains
|
7/9/2018 | DD | Market Commentary: American Tire notes begin week level; Community Health issues mixed as new issue comes to market
|
6/7/2018 | DD | Market Commentary: Endo notes see unexplained spike in volume; PetSmart mixed a day after hiring advisers
|
10/23/2017 | DD | Market Commentary: Walter Investment bonds jump, converts slide on reorganization plan news; healthcare, retail names active
|
8/16/2017 | BKCVDDEMIGPV | Market Commentary: New high-yield bonds eyed; Tesla trades active; Staples hits par; Trinseo performs well
|
8/8/2017 | DD | Market Commentary: Valeant results beat, bonds firm; Endo earnings better, but forecasts lowered; Depomed convertibles tank
|
8/7/2017 | DD | Market Commentary: Mallinckrodt debt dips on InfaCare purchase; Endo, Valeant earnings on tap; Fannie Mae trades up
|
7/17/2017 | DD | Market Commentary: iHeart bonds trade up on restructuring news; Valeant perks up on asset sale; Endo, Frontier busy, better
|
7/14/2017 | DD | Market Commentary: Distressed debt trading takes a breather at week’s end; Endo bonds trade active, but unchanged
|
6/22/2017 | DD | Market Commentary: Senate health care drives Valeant, Community Health higher; E&P up with oil gains; PetSmart continues slide
|
6/20/2017 | DD | Market Commentary: Existing Intelsat issues lower after new deal sets in; E&P falls as oil enters bear market; Valeant reverses course
|
6/5/2017 | DD | Market Commentary: Mallinckrodt down on price-gouging report; Walter Investment up on debt adviser news; California Resources drift
|
5/11/2017 | DD | Market Commentary: Valeant mixed, less active; Cengage down on earnings, Talen up; Intelsat mixed on extension
|
5/8/2017 | DD | Market Commentary: California Resources leads most-active for second-straight session; GenOn, Talen higher; Neiman unchanged
|
5/5/2017 | DD | Market Commentary: Post earnings, California Resources up as crude oil rebounds; GenOn ‘not as active,’ but up; Revlon, Neiman down
|
5/3/2017 | DD | Market Commentary: Earnings-related activity moves Community Health, Fresh Market, CF Industries; California Resources goes low
|
4/25/2017 | DD | Market Commentary: Freeport McMoRan, Avaya tick higher on company-related news; Ocwen ‘volatile’; Community Health gains
|
4/13/2017 | BKCVDDEMIGPV | Market Commentary: Air Methods deal caps shortened $3 billion week; Wednesday deals busy, funds off $348 million
|
4/13/2017 | DD | Market Commentary: Claire’s, Quorum Health trade higher after fourth-quarter earnings; iHeart ‘better,’ but not much volume
|
4/12/2017 | BKCVDDEMIGPV | Market Commentary: SNF Floerger, Tutor Perini, Endo, Tennant price; Toys ‘R’ Us jumps; recent issues mixed
|
4/12/2017 | DD | Market Commentary: Toys ‘R’ Us up several points after posting fourth quarter results; Endo International rebounds; Valeant down
|
4/11/2017 | BKCVDDEMIGPV | Market Commentary: Upsized Barminco prices; Petsmart ticks higher; recent Ultra Petroleum, Cedar Fair mixed
|
4/11/2017 | DD | Market Commentary: Petsmart ticks higher as most active issue; Gymboree, GulfMark see headlines but no movement
|
4/10/2017 | DD | Market Commentary: E&P’s trade tight after oil gains for fifth day; Endo higher after offering announcement; Petsmart volume heavy
|
4/7/2017 | DD | Market Commentary: Cobalt International bounces around before 10-point upswing; FirstEnergy higher; pharma mixed; retailers tight
|
2/28/2017 | DD | Market Commentary: Intelsat sees gains after confirming merger with OneWeb; Valeant down post-results; Endo, Neiman unchanged
|
1/30/2017 | DD | Market Commentary: Intelsat sees gains for third straight session; Neiman down a ‘smidge’; Peabody pares loss; E&P mixed
|
12/21/2016 | DD | Market Commentary: iHeart steals action with ruling, moving notes both ways; Peabody down on operating loss; Valeant mixed
|
12/15/2016 | DD | Market Commentary: Overall quiet in distressed market, although Valeant swings; Peabody decline continues; energy down
|
11/8/2016 | DD | Market Commentary: Valeant takes nosedive after earnings announced; Concordia continues plunge; Alliance, Endo see movement
|
10/13/2016 | DD | Market Commentary: Valeant drops with Q3 announcement on horizon; Nortel up after settlement; Alliance leaks after deal
|
5/7/2016 | DD | Market Commentary: Chesapeake, California Resources down; Endo plunges on guidance cut; Penney off on belt tightening
|
5/6/2016 | BKCVDDEMIGPV | Market Commentary: Primary ends week quietly though upcoming week seen busy; Endo falls on reduced guidance
|
10/24/2015 | DD | Market Commentary: Valeant leads pharma rebound; Platform Specialty off as CEO plans exit; energy names slide
|
10/23/2015 | BKCVDDEMIGPV | Market Commentary: Pharmaceutical, hospital names rebound; Asbury add-on closes $1.65 billion primary week
|
10/23/2015 | DD | Market Commentary: Valeant, other drug makers continue slide; hospital names trade off; oil credits again lower
|
10/22/2015 | BKCVDDEMIGPV | Market Commentary: Hospital names fall on Community Health earnings warning; funds see $3.34 billion inflow
|
10/22/2015 | DD | Market Commentary: Valeant debt clobbered as report alleges fraud; other pharmaceuticals fall; oil credits lower
|
10/21/2015 | BKCVDDEMIGPV | Market Commentary: Valeant crushed as short-seller’s report alleges fraud; Jarden prices; Globo postpones
|
6/26/2015 | BKCVDDEMIGPV | Market Commentary: Downsized Intrepid Aviation caps busier $5.66 billion week; California Resources retreats
|
6/25/2015 | BKCVDDEMIGPV | Market Commentary: TI Automotive prices; Endo deal adds to gains; Valeant off on M&A; funds up $621 million
|
6/24/2015 | BKCVDDEMIGPV | Market Commentary: Upsized Endo megadeal, CyrusOne add-on, Univar price; new Endo jumps in heavy trading
|
6/22/2015 | BKCVDDEMIGPV | Market Commentary: Ball Corp., AerCap megadeals drive by; Williams, Energy Transfer gyrate on takeover offer
|
6/19/2015 | BKCVDDEMIGPV | Market Commentary: Downsized Eclipse Resources prices to cap $2.9 billion week; new Hologic, Tribune issues busy
|
3/12/2015 | BKCVDDEMIGPV | Market Commentary: United Rentals two-parter, CenturyLink price; Valeant upsizes; funds lose $1.96 billion
|
3/11/2015 | BKCVDDEMIGPV | Market Commentary: Shea Homes two-parter, Surgical Care, GFL deals price; Valeant up on Endo bid for Salix
|
1/28/2015 | BKCVDDEMIGPV | Market Commentary: Primary again quiet, but calendar grows; new Heinz busy; Caesars slides on court ruling
|
1/21/2015 | BKCVDDEMIGPV | Market Commentary: Primary quieter, with Nexstar sole dollar pricing; Endo heavily traded; Caesars shoots upward
|
1/20/2015 | BKCVDDEMIGPV | Market Commentary: Post-holiday primary cooks with Zayo, Endo, HealthSouth drive-bys; new, recent deals busy
|
6/25/2014 | BKCVDDEMIGPV | Market Commentary: Upsized Memorial Resource, Endo drive-by, CNH pace $2.2 billion day; Memorial moves up
|